GSBS Dissertations and Theses

Publication Date

2014-07-30

Document Type

Master's Thesis

Academic Program

Master of Science in Clinical Investigation

Department

Quantitative Health Sciences

First Thesis Advisor

Robert Goldberg, PhD

Keywords

Comorbidity, Heart Failure, Outcome Assessment (Health Care), Chronic Obstructive Pulmonary Disease

Subjects

Theses, UMMS; Comorbidity; Heart Failure; Outcome Assessment (Health Care); Pulmonary Disease, Chronic Obstructive

Abstract

Objective: Chronic obstructive pulmonary disease (COPD) is a common comorbidity in patients with heart failure, yet little is known about the impact of this condition in patients with acute decompensated heart failure (ADHF), especially from a more generalizable, community-based perspective. The primary objective of this study was to describe the in-hospital and post discharge mortality and treatment of patients hospitalized with ADHF according to COPD status.

Methods: The study population consisted of patients hospitalized with ADHF at all 11 medical centers in central Massachusetts during 4 study years: 1995, 2000, 2002, and 2004.

Results: Of the 9,748 patients hospitalized with ADHF during the years under study, 35.9% had a history of COPD. The average age of this population was 76.1 years, 43.9% were men, and 93.3% were white. At the time of hospital discharge, patients with COPD were less likely to have received evidence-based heart failure medications, including beta-blockers and ACE inhibitors/angiotensin receptor blockers, than patients without COPD. Multivariable adjusted in-hospital death rates were similar for patients with and without COPD. However, among patients who survived to hospital discharge, patients with COPD had a significantly higher risk of dying at 1 (adjusted RR 1.10; 95% CI 1.06, 1.14) and 5-years (adjusted RR 1.40; 95% CI 1.28, 1.42) after hospital discharge than patients who were not previously diagnosed with COPD.

Conclusions: COPD is a common co-morbidity in patients hospitalized with ADHF and is associated with a worse long-term prognosis. Further research is required to understand the complex interactions of these diseases and to ensure that patients with ADHF and COPD receive optimal treatment modalities.

DOI

10.13028/M2Z317

Rights and Permissions

Copyright is held by the author, with all rights reserved.

Download

Share

COinS